Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders
CA 2448025 C · Owner: Mueller, Norbert · Inventors: Mueller, Norbert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns the use of a COX-2 inhibitor for the treatment of psychiatric disorders such as schizophrenia delusional disorders, affective , disorders autism or tic disorders, in particular chronic schizophrenic psychoses and schizoaffective psychoses temporary acute psychotic disorders, depressive episodes recurring depressive episodes, manic episodes and bipolar affective disorders. Moreover, the invention is concerned with the use of a COX-2 inhibitor, in particular celecoxib in combination with a neuroleptic , drug in particular risperidone, or an antidepressant for the treatment of , psychiatric disorders such as schizophrenia delusional disorders, affective , disorders …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 31, 2002 and granted July 5, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 31, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 31, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.